Skip to main content

Table 3 Association between METS-IR (per 1 unit increase) and AF recurrence

From: Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study

 

Model 4

Model 5

Model 6

HR (95%CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

METS-IR

1.04 (1.03–1.06)

< 0.001

1.04 (1.03–1.06)

< 0.001

1.04 (1.03–1.05)

< 0.001

< 40.889

Reference

Reference

Reference

≥ 40.889

1.78 (1.54–2.07)

< 0.001

1.84 (1.58–2.13)

< 0.001

1.62 (1.38–1.89)

< 0.001

M1

Reference

Reference

Reference

M2

1.32 (1.08–1.61)

0.007

1.34 (1.10–1.63)

0.004

1.26 (1.02–1.54)

0.030

M3

2.05 (1.71–2.47)

< 0.001

2.14 (1.77–2.58)

< 0.001

1.82 (1.50–2.22)

< 0.001

  1. AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; METS-IR, metabolic score for insulin resistance; M1: METS-IR ≤ 35.585; M2: 35.585 < METS-IR ≤ 40.863; M3: 40.863 < METS-IR
  2. Model 4: Unadjusted
  3. Model 5: Adjusted for age and sex
  4. Model 6: Adjusted for age, sex, current drinking, diabetes mellitus, hyperlipidemia, coronary heart disease, duration of AF (≥ 24 months), AF type, HbA1c, left atrial diameter, platelet, CHA2DS2-VASc score